The Effect of Noopept on Neurochemical Changes in the Retina during the Experimental Thrombosis of Its Vessels

2019 ◽  
Vol 13 (1) ◽  
pp. 62-67
Author(s):  
A. V. Kolesnikov ◽  
A. V. Shchul’kin ◽  
O. I. Barenina ◽  
E. N. Yakusheva ◽  
V. S. Kudrin ◽  
...  
1985 ◽  
Vol 53 (03) ◽  
pp. 423-427 ◽  
Author(s):  
Stephen R Hanson ◽  
Laurence A Harker

SummarySuloctidil has been evaluated in the baboon for its antithrombotic efficacy using models of both acute and chronic arterial thrombogenesis. Acute thrombus formation was initiated by Dacron vascular grafts inserted as extension segments into chronic arteriovenous shunts. 111In-platelet deposition was measured by scintillation camera imaging for one hour. The results after oral administration of suloctidil (100 mg/kg/d in two divided doses) were not different from control studies. Moreover, concurrent heparin anticoagulation did not affect 111In-platelet deposition compared with control data. In contrast, ticlopidine (20 mg/ kg/d) significantly decreased platelet deposition that was reduced further by the addition of heparin.Chronic arterial-thromboembolism was initiated by segments of polyurethane (Biomer) cannula introduced into chronic arteriovenous shunts. Thrombus formation by the polyurethane cannula was measured as 111In-platelet turnover (corrected for removal of senescent platelets). Cannula platelet consumption was unaffected by suloctidil (20 mg/kg/d given in two divided doses for two days preceding and throughout the period of platelet survival measurement). In contrast, dipyridamole (10 mg/ kg/d) and sulfinpyrazone (100 mg/kg/d) completely interrupted cannula platelet consumption.We conclude that suloctidil probably has little or no effect on platelet-dependent thrombus formation.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Tun-Wei Hsu ◽  
Jong-Ling Fuh ◽  
Da-Wei Wang ◽  
Li-Fen Chen ◽  
Chia-Jung Chang ◽  
...  

AbstractDementia is related to the cellular accumulation of β-amyloid plaques, tau aggregates, or α-synuclein aggregates, or to neurotransmitter deficiencies in the dopaminergic and cholinergic pathways. Cellular and neurochemical changes are both involved in dementia pathology. However, the role of dopaminergic and cholinergic networks in metabolic connectivity at different stages of dementia remains unclear. The altered network organisation of the human brain characteristic of many neuropsychiatric and neurodegenerative disorders can be detected using persistent homology network (PHN) analysis and algebraic topology. We used 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging data to construct dopaminergic and cholinergic metabolism networks, and used PHN analysis to track the evolution of these networks in patients with different stages of dementia. The sums of the network distances revealed significant differences between the network connectivity evident in the Alzheimer’s disease and mild cognitive impairment cohorts. A larger distance between brain regions can indicate poorer efficiency in the integration of information. PHN analysis revealed the structural properties of and changes in the dopaminergic and cholinergic metabolism networks in patients with different stages of dementia at a range of thresholds. This method was thus able to identify dysregulation of dopaminergic and cholinergic networks in the pathology of dementia.


2021 ◽  
pp. 136014
Author(s):  
Daniela Silva Santos ◽  
Liciane Fernandes Medeiros ◽  
Dirson João Stein ◽  
Isabel Cristina De Macedo ◽  
Diego Evandro Da Silva Rios ◽  
...  

2015 ◽  
Vol 35 (8) ◽  
pp. 1798-1804 ◽  
Author(s):  
Sanjana Dayal ◽  
Sean X. Gu ◽  
Ryan D. Hutchins ◽  
Katina M. Wilson ◽  
Yi Wang ◽  
...  

2010 ◽  
Vol 32 (4) ◽  
pp. 498
Author(s):  
Damiyon Sledge ◽  
Ann Petro ◽  
Jerry Yen ◽  
Susan Donerly ◽  
Elwood Linney ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document